Mark E. Smolkin
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
Papers in
- Immunology 27
- Immunotherapy and Immune Responses 27
- Oncology 15
- Cancer Immunotherapy and Biomarkers 8
- Cutaneous Melanoma Detection and Management 5
- Co-authors
- Craig Lee Slingluff (34 shared papers)Gina R. Petroni (34 shared papers)Kimberly A. Chianese‐Bullock (21 shared papers)James W. Patterson (7 shared papers)Donna H. Deacon (13 shared papers)Lynn Thacher Dengel (6 shared papers)Gulsun Erdag (3 shared papers)William W. Grosh (14 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (10 papers)Cancer Immunology Immunotherapy (9 papers)Clinical Cancer Research (3 papers)Gynecologic Oncology (3 papers)Journal of Immunotherapy (3 papers)
- Partner nations
- United StatesQatarNetherlands
In The Last Decade
Mark E. Smolkin
87 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 120
- Immunology 1.2k
- Oncology 1.1k
- Family Practice 25
- Pulmonary and Respiratory Medicine 307
- Otorhinolaryngology 55
Countries citing papers authored by Mark E. Smolkin
This map shows the geographic impact of Mark E. Smolkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Smolkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Smolkin more than expected).
Fields of papers citing papers by Mark E. Smolkin
This network shows the impact of papers produced by Mark E. Smolkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Smolkin. The network helps show where Mark E. Smolkin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Smolkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 497 | |
| 2 | 2007 | 148 | |
| 3 | 2009 | 147 | |
| 4 | 2011 | 110 | |
| 5 | 2016 | 110 | |
| 6 | 2008 | 101 | |
| 7 | 2016 | 101 | |
| 8 | 2006 | 97 | |
| 9 | 2004 | 93 | |
| 10 | 2008 | 89 | |
| 11 | 2006 | 82 | |
| 12 | 2019 | 82 | |
| 13 | 2012 | 78 | |
| 14 | 2004 | 76 | |
| 15 | 2011 | 74 | |
| 16 | 2020 | 69 | |
| 17 | 2009 | 62 | |
| 18 | 2012 | 57 | |
| 19 | 2012 | 57 | |
| 20 | 2017 | 55 |
About Mark E. Smolkin
Mark E. Smolkin is a scholar working on Immunology, Oncology, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Neurology, having authored 89 papers that have together received 3.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (27 papers), Cancer Immunotherapy and Biomarkers (8 papers), Bladder and Urothelial Cancer Treatments (5 papers), Cutaneous Melanoma Detection and Management (5 papers), Endometrial and Cervical Cancer Treatments (4 papers), Cardiac, Anesthesia and Surgical Outcomes (4 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Glioma Diagnosis and Treatment (3 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (1.1k citations), Family Practice (25 citations), Pulmonary and Respiratory Medicine (307 citations) and Otorhinolaryngology (55 citations). Mark E. Smolkin has collaborated with scholars based in United States, Qatar and Netherlands. Frequent co-authors include Craig Lee Slingluff, Gina R. Petroni, Kimberly A. Chianese‐Bullock, James W. Patterson, Donna H. Deacon, Lynn Thacher Dengel, Gulsun Erdag, William W. Grosh, Walter C. Olson and Sofia M. Shea. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Cancer Immunology Immunotherapy, Clinical Cancer Research, Gynecologic Oncology and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.